DR. KELLY & PARTNERS
Vere Foster Medical Group, Vere Foster Medical Group, 132-136 Sandy Row, BELFAST
PP 1
In those patients with a new diagnosis of hypertension (excluding those with pre-existing CHD, diabetes, stroke and/or TIA) recorded between the preceding 1 April to 31 March: the percentage of patients who have had a face to face cardiovascular risk assessment at the outset of diagnosis using an agreed risk assessment treatment tool.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| PP 1 | 2010 | None | None | NA% | |
| PP 1 | 2011 | None | None | NA% | |
| PP 1 | 2012 | 11 | 23 | 47.8% | |
| PP 1 | 2013 | 18 | 24 | 75.0% | |
| CVD-PP011NI | 2015 | 13 | 14 | 92.9% | |
| CVD-PP011NI | 2016 | 18 | 20 | 90.0% | |
| CVD-PP011NI | 2017 | 18 | 20 | 90.0% | |
| CVD-PP011NI | 2018 | 20 | 22 | 90.9% | |
| CVD-PP011NI | 2019 | 15 | 16 | 93.8% | |
| CVD-PP011NI | 2020 | 8 | 16 | 50.0% | |
| CVD-PP011NI | 2021 | 9 | 14 | 64.3% |
